LobbyingTeladoc Health lobbying by quarter
Teladoc Health TDOC's latest lobbying report covers Q2 2026, at $330K. The four quarters Q3 2025–Q2 2026 total $1.4M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Teladoc HealthTDOC
- Latest quarter
- $330K
- Q2 2026 · 5 reports
- Last 12 months
- $1.4M
- Last 4 quarters
- vs last quarter
- −1.5%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $180K | 2 |
| Q1 2023 | $140K | 2 |
| Q2 2023 | $140K | 2 |
| Q3 2023 | $140K | 2 |
| Q4 2023 | $130K | 2 |
| Q1 2024 | $130K | 2 |
| Q2 2024 | $130K | 2 |
| Q3 2024 | $130K | 2 |
| Q4 2024 | $130K | 3 |
| Q1 2025 | $350K | 4 |
| Q2 2025 | $310K | 5 |
| Q3 2025 | $350K | 5 |
| Q4 2025 | $365K | 5 |
| Q1 2026 | $335K | 5 |
| Q2 2026 | $330K | 5 |
Policy issues the reports name
- Health issues40 reports
- Medicare and Medicaid25 reports
- Consumer protection and safety20 reports
- Insurance16 reports
- Taxation10 reports
- Telecommunications6 reports
- Government issues5 reports
- Veterans1 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE47 reports
- HOUSE OF REPRESENTATIVES46 reports
- Centers For Medicare and Medicaid Services (CMS)9 reports
- Office of Personnel Management (OPM)7 reports
- Health & Human Services, Dept of (HHS)2 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseTeladoc Health | $1.8M | 15 quarters |
| Mehlman Consulting | $900K | 15 quarters |
| The Petrizzo Group | $280K | 7 quarters |
| Atrio Consulting Group | $190K | 5 quarters |
| Veritas Health Policy | $90K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| EARL SCOTT FLOOD | Dep. CoS, LD (Rep. Robin Kelly); Health Pol Adv, Csl (Rep. Terri Sewell); Csl (Rep. Cedric Richmond); Pol Aide (Sen. Claire McCaskill) | Q2 2026 |
| RYAN LITTLE | H. Comm. on Oversight.: Dir. of Ext. Aff., Sen. Adv. & Dir. of Ops., Ops. Dir., Prof. Staff. Member, Mgr. Floor. Ops., Leg. Assistant. Rep. Chaffetz: Sen. Leg. Assistant. Rep. Issa: Leg. Corresp., & Staff Assistant. | Q1 2026 |
| JOSEPH EDWARD BROWN iii | Sr Prof Staff (EPW Comm Maj/Sen. Moore Capito); Prof Staff (EPW Comm Min/Ranking Mem Sen. Moore Capito); Leg Asst (Sen. Boozman); Maj Leg Asst (EPW Comm Maj/Sen. Jim Inhofe); Maj Research Asst (EPW Comm Maj/Sen. Jim Inhofe); Intern (Rep. Jim Renacci) | Q3 2025 |
| JON ADAME | CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici) | Q2 2025 |
| ANNIE WOLF | Dep Floor Dir (Maj Leader Scalise); CoS (Chief Dep Min Whip Ferguson); Dep Floor Dir (Min Whip Scalise); Prof Staff (House Rules/Sessions); Floor Asst (Speakers Ryan & Boehner); Staff Asst (Speaker Boehner); Intern (Rep. Sullivan) | Q3 2024 |
| NAVEEN PARMAR | Chief Counsel (Sen. Hickenlooper); General Counsel (House Comm on Sm Bus/Velazquez); Tax Counsel, (House Comm on Sm Bus/Velazquez); Economic Policy Counsel (Sen. Amy Klobuchar); Ways and Means Counsel (Rep. Lloyd Doggett) | Q3 2024 |
| ALYENE MLINAR | Pol Adv (Maj Leader Scalise); Pol Adv (Min Whip Scalise); Pol Adv (House Oversight/Govt Reform Comm); Prof Staff Member (Ways and Means Subcom on Health/Brady), Pol Adv (Sen Rep Policy Comm/Barrasso); Leg Asst (Senator Ben Sasse) | Q4 2023 |
| ERICA JAY CHABOT | Staff Asst, Leg Corres, Asst Schd, Asst to COS, Press Asst, Dep Press Sec, Leg Dir (Senator Patrick Leahy); Prof Staff (Sen Approp Comm); LD (Sen Pres Pro Temp Emeritus); Dep COS (Senate Consult); Staff Dir (Sen Ag Comm) | Q4 2023 |
| CAITLIN VAN SANT | Sr Pol Adv, Leg Dir, Interim COS (Rep. Butterfield) | Q4 2022 |
| LISA GOLDMAN | Sr Counsel, House Comm on Energy & Commerce; Chief Counsel, Sr Counsel (E&C Subcommittee on Consumer Protection & Commerce); Counsel House Comm on E&C | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Atrio Consulting Group | $40K |
| 07/20for Q2 | Veritas Health Policy | $20K |
| 07/20for Q2 | In-house | $170K |
| 07/17for Q2 | Mehlman Consulting | $60K |
| 07/13for Q2 | The Petrizzo Group | $40K |
| 04/20for Q1 | Atrio Consulting Group | $40K |
| 04/17for Q1 | Veritas Health Policy | $15K |
| 04/17for Q1 | Mehlman Consulting | $60K |
| 04/16for Q1 | In-house | $170K |
| 04/05for Q1 | The Petrizzo Group | $50K |
| 01/20for Q4 2025 | Atrio Consulting Group | $40K |
| 01/20for Q4 2025 | In-house | $200K |
| 01/19for Q4 2025 | Veritas Health Policy | $15K |
| 01/16for Q4 2025 | Mehlman Consulting | $60K |
| 01/13for Q4 2025 | The Petrizzo Group | $50K |
| 25/11/03for Q3 2025 | Atrio Consulting Group | $40K |
| 25/10/17for Q3 2025 | Mehlman Consulting | $60K |
| 25/10/17for Q3 2025 | In-house | $190K |
| 25/10/16for Q3 2025 | Veritas Health Policy | $15K |
| 25/10/13for Q3 2025 | The Petrizzo Group | $45K |